Cargando…
Aspirin use and bleeding events during thrombocytopenia after autologous stem-cell transplantation for multiple myeloma
BACKGROUND: In patients with cardiovascular (CV) comorbidities that necessitate antiplatelet therapy (APT), its optimal management during chemotherapy-induced thrombocytopenia remains elusive, as the risk of bleeding has to be balanced against the risk of CV events. The purpose of this study was to...
Autores principales: | Neuendorff, Nina Rosa, Boshikova, Boryana, Frankenstein, Lutz, Kirchner, Marietta, Rohde, Christian, Goldschmidt, Hartmut, Frey, Norbert, Müller-Tidow, Carsten, Jordan, Karin, Sauer, Sandra, Janssen, Maike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174307/ https://www.ncbi.nlm.nih.gov/pubmed/37182183 http://dx.doi.org/10.3389/fonc.2023.1168120 |
Ejemplares similares
-
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma
por: Baertsch, Marc-Andrea, et al.
Publicado: (2021) -
Antibiotic Prophylaxis or Granulocyte-Colony Stimulating Factor Support in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
por: Klein, Eva-Maria, et al.
Publicado: (2021) -
Clonal hematopoiesis with DNMT3A and PPM1D mutations impairs regeneration in autologous stem cell transplant recipients
por: Stelmach, Patrick, et al.
Publicado: (2023) -
Aspirin/enoxaparin-sodium: Atypical spontaneous haematomas, bleeding and thrombocytopenia: case report.
Publicado: (2020) -
High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting
por: Lisenko, Katharina, et al.
Publicado: (2017)